Naoki Yamashita Selected Research

Naoki Yamashita Research Topics

Disease

9	Fibrosis (Cirrhosis) 02/2022 - 03/2012
7	Infections 02/2022 - 01/2008
7	Chronic Hepatitis C 02/2022 - 02/2008
6	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 02/2005
4	Chronic Hepatitis B 04/2022 - 01/2008
4	Neoplasms (Cancer) 04/2021 - 11/2014
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 02/2012
2	Lung Neoplasms (Lung Cancer) 04/2021 - 11/2003
2	Liver Cirrhosis (Hepatic Cirrhosis) 08/2016 - 03/2012
1	Hepatitis 04/2022
1	Hepatitis B 01/2021
1	Virus Diseases (Viral Diseases) 05/2020
1	Insulin Resistance 01/2020
1	Overweight 01/2020
1	Diabetes Mellitus 05/2018
1	Pleural Effusion (Pleural Effusions) 03/2017
1	Fistula 03/2017
1	Empyema 03/2017
1	Pleural Empyema (Pyothorax) 03/2017
1	Acute Liver Failure (Fulminant Hepatic Failure) 08/2016
1	Hypoxia (Hypoxemia) 06/2016
1	Liver Failure 06/2016
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 06/2016
1	Leukemia 04/2015
1	Infertility (Sterility) 04/2015
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2015
1	Primary Ovarian Insufficiency 04/2015
1	Carcinoma (Carcinomatosis) 11/2014
1	Carcinogenesis 11/2014
1	Inflammation (Inflammations) 06/2013
1	Epistaxis (Nosebleed) 02/2012
1	Hyperuricemia 02/2008
1	Non-alcoholic Fatty Liver Disease 01/2008
1	Neoplasm Metastasis (Metastasis) 02/2005
1	Idiopathic Pulmonary Fibrosis 11/2003

Drug/Important Bio-Agent (IBA)

7	InterferonsIBA 02/2022 - 03/2010
6	Antiviral Agents (Antivirals)IBA 02/2022 - 05/2019
3	tenofovir alafenamideIBA 04/2022 - 01/2021
3	entecavir FDA Link 04/2022 - 01/2021
2	Tenofovir (Viread)FDA Link 04/2022 - 01/2022
2	pibrentasvirIBA 08/2020 - 05/2020
2	glecaprevirIBA 08/2020 - 05/2020
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 08/2016 - 06/2016
2	Ribavirin (Virazole)FDA LinkGeneric 03/2012 - 02/2008
1	Surface Antigens (Surface Antigen)IBA 04/2022
1	AldehydesIBA 01/2022
1	A 17 (A-17)IBA 04/2021
1	Alanine Transaminase (SGPT)IBA 01/2021
1	AntigensIBA 01/2021
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2021
1	SofosbuvirIBA 12/2020
1	velpatasvirIBA 12/2020
1	glecaprevir and pibrentasvirIBA 05/2020
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2020
1	Blood Glucose (Blood Sugar)IBA 01/2020
1	CreatinineIBA 01/2020
1	FructoseIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Insulin (Novolin)FDA Link 01/2020
1	HDL CholesterolIBA 01/2020
1	Advanced Glycation End ProductsIBA 01/2020
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2020
1	AdiponectinIBA 01/2020
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 05/2018
1	asunaprevirIBA 03/2017
1	daclatasvirIBA 03/2017
1	SimeprevirIBA 03/2017
1	Protease Inhibitors (Protease Inhibitor)IBA 03/2017
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 08/2016
1	Sorafenib (BAY 43-9006)FDA Link 08/2016
1	regorafenibIBA 06/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2015
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 11/2014
1	Bevacizumab (Avastin)FDA Link 02/2012
1	RNA (Ribonucleic Acid)IBA 03/2010
1	Liver X ReceptorsIBA 01/2008
1	LipidsIBA 01/2008
1	Lamivudine (Epivir)FDA Link 01/2008
1	adefovir dipivoxil (Hepsera)FDA Link 01/2008
1	DNA (Deoxyribonucleic Acid)IBA 01/2008
1	Sterol Regulatory Element Binding Protein 1IBA 01/2008
1	titanium silicide (TS-1)IBA 02/2005

Therapy/Procedure

7	Therapeutics 01/2021 - 02/2008
2	Drug Therapy (Chemotherapy) 04/2015 - 02/2012
1	Duration of Therapy 08/2020
1	Oral Administration 01/2020
1	Thoracoplasty 03/2017
1	Chest Tubes (Chest Tube) 03/2017
1	Curettage 03/2017
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 04/2015
1	Hematopoietic Stem Cell Transplantation 04/2015
1	Metastasectomy 02/2015
1	Hepatectomy 02/2015
1	Contraindications 11/2003